Accepted Abstracts
See the research works accepted for presentation at CannX Tel Aviv 2022 and their allocation per categories.
ID 112
SCI: Innovations in Science and Medicine
CANNABIDIOL DOWNREGULATES THE EXPRESSION OF THE HUMAN FAM111B GENE IN LUNG ADENOCARCINOMA
A. Arowolo1, M. Malebana1, F. Sunda1, C. Rhoda1
1University of Cape Town, Medicine (division Of Dermatology), Cape Town, South Africa
ID 79
SCI: Innovations in Science and Medicine
MEDICAL CANNABIS SIGNIFICANTLY DECREASES AVERAGE PAIN SCORE FOLLOWING ONLY THREE MONTHS OF USE
R. Duda1, A. Garibaldi2, K. Mahabir2, C. Smith2, C. Vannabouathong2
1BIDMC/HMS, Surgical Oncology, Boston, United States of America
2Skylight Health Group, Research, Ontario, Canada
ID 23
SCI: Innovations in Science and Medicine
NOVEL CANNABIDIOL (CBD)-INFUSED ABSORBABLE IMPLANT DELIVERY SYSTEM FOR NEUROTRAUMA
L. Friedman1, R. Zeman1
1New York Medical College, Cell Biology And Anatomy, Valhalla, United States of America
ID 69
SCI: Innovations in Science and Medicine
CANNABINOIDS AND CANNABIS EXTRACTS AFFECT METABOLIC SYNDROME PARAMETERS INCLUDING MICROBIOME IN MICE FED HIGH FAT-CHOLESTEROL DIET
J. Gorelick1, N. Bernstein2, Z. Madar3
1Merkaz Yehudah, Eastern Regional Research And Development Center, Kiryat Arba, Israel
2Volcani Institute, Institute Of Soil, Water And Environmental Sciences, Rishon LeZion, Israel
3The Hebrew University of Jerusalem,, The Robert H Smith Faculty Of Agriculture, Food And Environment,, Rehovot, Israel
ID 30
SCI: Innovations in Science and Medicine
METABOLIC EFFECTS OF MEDICAL CANNABIS TREATMENT
G. Habib1, S. Aamar2
1Laniado Hospital and Nazareth Hospital, Rheumatology Unit, Netanya & Nazareth, Israel
2Hadassah Mount Scopus-Hebrew University Medical School, Jerusalem,, Rheumatology Unit, Jerusalem, Israel
ID 139
SCI: Innovations in Science and Medicine
OBJECTIVE QUANTIFICATION OF THE IMPACT OF MEDICAL CANNABIS TREATMENT USING CANNABIS-RESPONSIVE BIOMARKERS
B. Goldstein1, I. Kurek2
1Canna-Centers Wellness & Education, Medical, Rolling Hills Est, United States of America
2Cannformatics, Science, San Francisco, United States of America
ID 56
SCI: Innovations in Science and Medicine
PRE-CLINICAL TOXICITY OF CANNBIGEROL IN RATS AND C. ELEGANS
T. Lefever1, K. Trexler1, M. Toth2, L. Macnair1, S. Vanapalli2, S. Gupta2, M. Rahman2, M. Bonn-Miller3
1Canopy Growth, Pre-clinical & Safety, Ontario, Canada
2NemaLife Inc., N/a, Lubbock, United States of America
3Canopy Growth, Human & Animal Research, Smiths Falls, Canada
ID 137
Innovations in Science and Medicine
CANNABIS USE IN GASTROINTESTINAL DISORDERS
M. Neuman1, L. Cohen2, S. Malnick3
1In Vitro Drug Safety and Biotechnology, Pharmacology And Toxicology, University Of Toronto, Toronto, Canada
2Sunnybrook HSC, Gastroenterology, Ontario, Canada
3Kaplan Medical Center, Rehovot, Affiliated to Hebrew University, Internal Medicine C, Jerusalem, Israel
ID 72
Innovations in Science and Medicine
ADDRESSING THE OPIOID EPIDEMIC WITH RESEARCH AND REAL-WORLD DATA-INFORMED APPROACHES.
M. McNabb1, D. Berman2, D. Ritter1, M. Ogen2, S. White3
1Cannabis Center of Excellence, Inc, Research Department, Boston, United States of America
2CannabisBPO, Executive, Americus, United States of America
3UMass Dartmouth, Charlton College Of Business, Dartmouth, United States of America
ID 38
SCI: Innovations in Science and Medicine
CANNABIS IN MIGRAINE
L. Mechtler
DENT Neurologic Institute/NeuroNet Pro/American Society Of Neuroimaging, Neurology/neuro-oncology/cannabis, Buffalo, United States of America
ID 93
SCI: Innovations in Science and Medicine
POSSIBLE MODULATION OF THE NEURO-ENDOCRINE-CYTOKINE NETWORK BY THE PINEAL HORMONE MELATONIN AND CANNABIDIOL IN PSYCHOLOGY
G. Messina, P. Lissoni
International Institute of Pnei, Psycho-oncology, Milan, Italy
ID 74
SCI: Innovations in Science and Medicine
FEMALES REPORT MORE ADVERSE EVENTS AND HIGHER NEGATIVE SUBJECTIVE EFFECTS IN MULTIPLE-DOSE TRIALS OF TWO ORAL MEDICAL CANNABIS PRODUCTS
L. Macnair1, E. Peters1, G. Eglit1, I. Mosesova1, M. Ware2, C. Turcotte1, M. Bonn-Miller1
1Canopy Growth Corporation, Human And Animal Research Program, Smiths Falls, Canada
2Canopy Growth, Office Of The Chief Medical Officer, Smiths Falls, Canada
ID 66
SCI: Innovations in Science and Medicine
EFFECT OF A CANNABIS EXTRACT ON ACUTE PAIN AND ON ANALGESICS REQUIREMENTS: A DOUBLE-BLINDED, RANDOMIZED, 24 HOURS FOLLOW-UP STUDY
E. Davidson1, A. Eyal2, N. Raz2
1Hadassah Hebrew University Hospital, Department Of Anesthesiology, Ccm And Pain Relief, Jerusalem, Israel
2Bazelet Medical Cannabis Group, R&d, Or Akiva, Israel
ID 52
SCI: Innovations in Science and Medicine
THE CHEMOTYPES I AND III OF CANNABIS SATIVA L INDUCE DISTINCT TYPES OF CELL DEATH (APOPTOSIS / NECROSIS) IN HUMAN LEUKEMIC CELL LINES
S. Santander Gonzalez1, M. Rodríguez1, L. Contreras1, M. Pombo2, A. Mejia2, G. Modesti3
1Phyto Immunomodulation group. University Foundation Juan N Corpas, Medical School,, Bogotá, Colombia
2Group of Plant Pharmacology and Alternative Therapeutics, University Foundation Juan N Corpas, Medical School, Bogotá, Colombia
3Phytochemical research group. Pontificia University Javeriana., Chemistry, Bogotá, Colombia
ID 49
SCI: Innovations in Science and Medicine
ADHERENCE, SAFETY AND EFFECTIVENESS OF MEDICAL CANNABIS AND EPIDEMIOLOGICAL CHARACTERISTICS OF THE PATIENT POPULATION: A PROSPECTIVE STUDY
L. Schleider1, R. Mechoulam2, I. Sikorin3, T. Naftali4, V. Novack1
1Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Clinical Research Center, Be’er-Sheva, Israel
2The Hebrew University of Jerusalem, School Of Pharmacy, Jerusalem, Israel
3Tikun‑Olam Cannbit Pharmaceuticals, Research Department, Tel-Aviv, Israel
4Meir Medical Center, Department Of Gastroenterology And Hepatology, Kfar Saba, Israel
ID 146
SCI: Innovations in Science and Medicine
DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY OF CANNABIDIOL CONTAINING FACIAL SERUMS
E. Tavčar, N. Kugonič, S. Kreft
University of Ljubljana, Faculty Of Pharmacy, Ljubljana, Slovenia
ID 95
SCI: Innovations in Science and Medicine
VAPORISED MEDICAL GRADE CANNABINOIDS AS RESCUE MEDICATION IN ACUTE ANXIETY – A VALIDATION AUDIT OF ADULTS PATIENTS IN AN URGENT CARE DEPARTMENT
G. Xantus
University of Pécs, Emergency Department, Pécs, Hungary
ID 113
SCI: Innovations in Science and Medicine
HARNESSING CANNABIS MOLECULES TO FIGHT INFLAMMATION-ASSOCIATED DEPRESSION
R. Yirmiya, H. Goldenberg, E. Robinson, E. Dinur, L. Naggan, H. Verdiger, E. Kozela
The Hebrew University of Jerusalem, Psychology, Jerusalem, Israel
ID 134
BIZ: New Technologies, New Opportunities
EVIDENCE-BASED CUSTOMER DISCOVERY AS A FIRST STEP FOR DEVELOPING A DECENTRALIZED CLINICAL RESEARCH PLATFORM FOR MEDICAL CANNABIS
C. Fitzer-Attas1, S. Joshi2, C. Pascal3
1ClinMed LLC, Clinical Research & Medical Affairs, Dayton, United States of America
2Rutgers University, Biomedical Engineering, New Brunswick, United States of America
3Rutgers University, Library And Information Science, New Brunswick, United States of America
ID 77
BIZ: New Technologies, New Opportunities
WHY PORTUGAL MAY BE THE IDEAL HUB FOR MEDICAL CANNABIS IN EUROPE?
F. Frazão Aguiar
WISE HS, Medical Cannabis, Porto, Portugal
ID 140
BIZ: New Technologies, New Opportunities
A NOVEL EDUCATIONAL TOOL FOR DISPENSARY STAFF AND PATIENTS: MEDICAL CANNABIS EDUCATION APP
R. Galamaga1, M. Mitra2, K. Reeder3, J. Harp4, D. Hall4
1Caduceus Medical Consulting, Medicine, Chicago, United States of America
2University of Maryland, Natural Sciences, princess ann, United States of America
3Cannatracker, Education, Rockville, United States of America
4University of Maryland, Pharmacy, Rockville, United States of America
ID 57
BIZ: New Technologies, New Opportunities
CONTROLLED AND RAPID DRYING OF MEDICAL CANNABIS INFLORESCENCES BY RADIO FREQUENCY METHOD
A. Uziel1, L. Milay2, S. Procaccia1, R. Cohen3, A. Burstein3, D. Lewitus4, D. Meiri1
1Technion Israel Institute of Technology, Biology, Haifa, Israel
2CannaSoul Analytics, Projects, Caesarea, Israel
3Goji, Research, Kfar saba, Israel
4Shenkar – Engineering Art Design, Department Of Polymers And Plastics Engineering, Ramat-Gan, Israel
ID 84
AGR: Advanced Agriculture and Production
PRODUCTIVITY EFFECTS OF THREE SINGLE PLANT GROWTH PROMOTING RHIZOBACTERIA INOCULATION ON CANNABIS SATIVA L. GROWTH AND FLOWER YIELD AND CANNABINOIDS PROFILE
D. Lyu, R. Backer, D. Smith
McGill University, Plant Science, SAINTE-ANNE-DE-BELLEVUE, Canada
ID 64
AGR: Advanced Agriculture and Production
VEGETATIVE PROPAGATION EXPERIMENTS ON MEDICINAL CANNABIS (CANNABIS SATIVA L.)
S. Moerenhout1, M. Holweg2
1Cultivators, Managing Partner, Etten-Leur, Netherlands, 2Cultivators, Research, Etten-Leur, Netherlands
ID 105
AGR: Advanced Agriculture and Production
UTILIZATION OF BENEFICIAL AND HIGHLY-EFFICACIOUS PHYTOMICROBIOME TECHNOLOGIES EFFECTS IN PRODUCTION OF CANNABIS SATIVA
D. Smith
McGill University, Plant Science, SAINTE-ANNE-DE-BELLEVUE, Canada
ID 50
SCI: Innovations in Science and Medicine
NITROGEN CONTAINING CANNABINOLIC ACIDS DERIVATIVES AS A NEW ANTICANCER DRUGS
A. Aizikovich
AL&AM Pharmachem Ltd, Cannabinoid Medicinal Chemistry, Rehovot, Israel
ID 96
SCI: Innovations in Science and Medicine
CANNABIS PRODUCTS IN POORLY REGULATED MARKETS: PUBLIC HEALTH, ETHICS, AND MESSAGING
A. Budney, J. Borodovsky
Dartmouth College, Geisel School Of Medicine, Lebanon, United States of America
ID 83
SCI: Innovations in Science and Medicine
THERAPEUTIC DRUG MONITORING OF CANNABIDIOL AND IMMUNOSUPPRESSANTS IN A KIDNEY TRANSPLANT PATIENT. CASE REPORT
L. Cuñetti1, C. Maldonado2, M. Vázquez2, L. Manzo1, R. Peyraube3
1Instituto de Nefrología y Urología, Unidad De Trasplante Renal, Montevideo, Uruguay
2Facultad de Química UDELAR, Departamento De Ciencias Farmacéuticas, Montevideo, Uruguay
3Universidad Nacional de Rosario, Centro De Estudios Interdisciplinarios, Rosario, Argentina
ID 62
SCI: Innovations in Science and Medicine
MEDICAL CANNABIS AND QUALITY OF LIFE IN PEOPLE LIVING WITH HIV
F. De Aguiar1, P. Costa2, F. Neves3, V. Duque4
1Fundação Portuguesa A Comunidade Contra a SIDA, Psychology, Lisboa, Portugal
2Fundação Portuguesa A Comunidade Contra a SIDA, Research, Lisboa, Portugal
3Centro Hospitalar do Porto – Centro Materno Infantil, Anestesiologia, Porto, Portugal
4Centro Hospitalar e Universitário de Coimbra, Infeciologia, Coimbra, Portugal
ID 130
SCI: Innovations in Science and Medicine
HUMAN MILK FEEDING AND CANNABIS USE : RECOMMENDATIONS FROM THE FIELD POST CANNABIS LEGALIZATION IN VERMONT
J. Dolan
CannaMommy Non-profit, Director, Underhill, VT, United States of America
ID 31
SCI: Innovations in Science and Medicine
INHIBITION OF HEPATOCELLULAR CARCINOMA GROWTH AND LIVER FIBROSIS BY NANOMOLAR CANABINOID CONCENTRATIONS
I. Itzhak, F. Barer, P. Fishman
Can-Fite BioPharma, Molecular Biology Labs, Petach-Tikva, Israel
ID 59
SCI: Innovations in Science and Medicine
CANNABIS STRAINS AND CANNABINOIDS PLAY KEY ROLE IN MODULATION OF NEUROINFLAMMATION
S. Fleisher-Berkovich1, Y. Ventura1, V. Feinshtein1, N. Bernstein2, J. Gorelick3, S. Ben-Shabat1
1Ben-Gurion University of the Negev, Clinical Biochemistry And Pharmacology, Beer-Sheva, Israel
2Volcani Center, Institute Of Soil, Water And Environmental Sciences, Rishon Lezion, Israel
3Judea center, Eastern Regional Research And Development Center, Kiryat Arba, Israel
ID 71
SCI: Innovations in Science and Medicine
INHALED CBD PHARMACOKINETIC PROFILE IN RATS
K. Trexler1, J. Macdonald2, D. Schwotzer2, M. Bonn-Miller3, M. Ware4, T. Lefever1
1Canopy Growth, Pre-clinical & Safety, Ontario, Canada
2Lovelace Biomedical, Life Sciences, Albuquerque, United States of America
3Canopy Growth, Human & Animal Research, Smiths Falls, Canada
4Canopy Growth, Office Of The Chief Medical Officer, Smiths Falls, Canada
ID 53
SCI: Innovations in Science and Medicine
CANNABIDIOL REDUCES EXTRACELLULAR LEVELS OF GLUTAMATE IN HIPPOCAMPUS OF RATS WITH TEMPORAL LOBE EPILEPSY
C. Martínez-Aguirre1, C. Santiago-Castañeda1, M. Cuéllar-Herrera2, L. Rocha-Arrieta1
1Center for research and advanced studies, Pharmacobiology, Ciudad de Mexico, Mexico
2Hospital General de México Dr. Eduardo Liceaga, Epilepsy Clinic, Ciudad de Mexico, Mexico
ID 26
SCI: Innovations in Science and Medicine
MEDICAL CANNABIS IN THE ELDERLY POPULATION
L. Mechtler1, M. Caserta2
1DENT Neurologic Institute/NeuroNet Pro/American Society Of Neuroimaging, Neurology/neuro-oncology/cannabis, Buffalo, United States of America
2DENT Neurologic Institute, Neurology/neuro-oncology/cannabis, Buffalo, United States of America
ID 34
SCI: Innovations in Science and Medicine
CAROTENOIDS AND CANNABINOIDS: AN INNOVATIVE ANTI-INFLAMMATORY COMBINATION
T. Offer1, Y. Solomonov1, R. Levy2
1Lycored, Global R&d, Beer Sheva, Israel
2BGU, Clinical Biochemistry, Beer Sheva, Israel
ID 33
SCI: Innovations in Science and Medicine
MEDICAL CANNABIS IN THE TREATMENT OF NEUROPATHY
C. Ralyea1, L. Mechtler2
1Dent Neurologic Institute, Cannabis Research Center, Amherst, United States of America
2DENT Neurologic Institute/NeuroNet Pro/American Society Of Neuroimaging, Neurology/neuro-oncology/cannabis, Buffalo, United States of America
ID 65
SCI: Innovations in Science and Medicine
OPTIMAL TREATMENT WITH CANNABIS OILS VIA ENRICHMENT WITH SPECIFICALLY SELECTED MONOTERPENES AND MONOTERPENOIDS
N. Raz1, A. Eyal1, D. Berneman Zeitouni1, E. Davidson2
1Bazelet Medical Cannabis Group, R&d, Or Akiva, Israel
2Hadassah Hebrew University Hospital, Department Of Anesthesiology, Ccm And Pain Relief, Jerusalem, Israel
ID 55
SCI: Innovations in Science and Medicine
CANNABIDIOL PRETREATMENT AVOIDS THE SHORT- AND LONG-TERM HIGH EXTRACELLULAR RELEASE OF GLUTAMATE SUBSEQUENT TO A SEVERE TRAUMATIC BRAIN INJURY
C.L. Santiago-Castañeda1, S. Huerta De La Cruz1, C. Martínez-Aguirre1, S.A. Orozco-Suarez2, L. Rocha-Arrieta1
1Center for Research and Advanced Studies (CINVESTAV), Pharmacobiology, Ciudad de Mexico, Mexico
2Specialties Hospital, National Medical Center SXXI (CMN-SXXI), Unit For Medical Research Neurological Diseases, Mexico, Mexico
ID 61
SCI: Innovations in Science and Medicine
NON-SYNCHRONOUS EVAPORATION OF CANNABIS’ ACTIVE INGREDIENTS – POTENTIAL IMPLICATIONS FOR SMOKING AND VAPING THE MEDICAL CANNABIS DRUG
D. Schlesinger, N. Raz, D. Berneman Zeitouni, D. Tal, A. Eyal
Bazelet Medical Cannabis Group, R&d, Or Akiva, Israel
ID 45
SCI: Innovations in Science and Medicine
CYTOTOXIC ACTIVITY OF Δ9–TETRAHYDROCANNABINOL (THC)-RICH COMPOSITIONS FROM CANNABIS AGAINST OVARIAN CANCER CELLS AND THEIR SYNERGY WITH NIRAPARIB.
N. Shalev1,2, H. Koltai2
1ARO- Volcani center, Plant Science, Rishon LeZion, Israel
2ARO-Volcani center, Plant Science, Rishon LeZion, Israel
ID 141
SCI: Innovations in Science and Medicine
TRISSOMY 21 AND LENNOX-GASTAUT SYNDROME: A REPORT OF IMPROVEMENT AFTER CANABIDIOL USE
R. Wajnsztejn1,2, R. Anghinah2
1University of ABC, Neurology, São Bernardo do Campo – SP, Brazil
2University of Sao Paulo, Neurology, São Bernardo do Campo, Brazil
ID 25
SCI: Innovations in Science and Medicine
EFFICIENT NEBULIZABLE CANNABINOID CARRYING CONTROLLED RELEASE SUSPENSIONS AND FORMULATIONS.
J. Wyse1, L. Lurya2
1Bressler IP, Patents, Ramat Gan, Israel
2Dr. Lurya Ltd, R&d, Jerusalem, Israel
ID 76
BIZ: New Technologies, New Opportunities
TRANSFORMING ACADEMIC EDUCATION AND RESEARCH AROUND CANNABIS LEGALIZATION, MEDICAL-USE CANNABIS, AND SOCIAL EQUITY IN NEW JERSEY
M. Mcnabb1, D. Ritter1, D. Berman2, M. Ogen2, S. Trocchio3, S. Scott4
1Cannabis Center of Excellence, Inc, Research Department, Boston, United States of America
2CannabisBPO, Executive, Americus, United States of America
3Rider University, Criminal Justice, Lawrenceville, United States of America
4Self, Senior Cannabis Consultant, Philadelphia, United States of America
ID 104
AGR: Advanced Agriculture and Production
CAN CARBON DOTS INCREASE SECOND METABOLITES LEVELS IN CANNABIS? A SOLID HYPOTHESIS.
P. Fortes1, S. Tinman2, N. Neto3, S. Beguerie4
1UFPI, Business, Teresina, Brazil
2Cannapi, Ceo, Sao Paulo, Brazil
3IESVAP, Medicine, Parnaíba, Brazil
4Alpha-CAT, Ceo, Prague, Czech Republic
ID 47
AGR: Advanced Agriculture and Production
PREDICTION OF PHYTOCANNABINOID AND TERPENE CONCENTRATIONS IN CANNABIS INFLORESCENCE USING NEAR-INFRARED SPECTROSCOPY AND CHEMOMETRICS
M. Birenboim1, D. Chalupowicz2, Y. Chen2, E. Falik2, D. Kengisbuch2, J. Shimshoni2
1The Robert H Smith Faculty of Agriculture, Food and Environment, Rehovot, Plant Science, Rehovot, Israel
2Volcani center, Institute For Postharvest And Food Sciences, rishon lezion, Israel
ID 70
AGR: Advanced Agriculture and Production
ANALYSIS OF MAIN ACTIVE SUBSTANCES IN DIFFERENT HEMP (CANNABIS SATIVA L.) PHENOTYPES
A. Čerenak1, M. Eržen1, I.J. Košir1, M. Ocvirk2, K. Rutnik2, S. Kreft3
1Slovenian Institute of Hop Research and Brewing, Department For Plants, Soil And Environment, Žalec, Slovenia
2Slovenian Institute of Hop Research and Brewing, Department For Agrochemistry And Brewing, Žalec, Slovenia
3University of Ljubljana, Faculty Of Pharmacy, Ljubljana, Slovenia
ID 102
AGR: Advanced Agriculture and Production
PAVING THE ROAD TO CANNABIS/HEMP STANDARDIZATION: MODERN AND NEW BREEDING TECHNOLOGIES (NBT’S) ACCELERATING CANNABIS VARIETY DEVELOPMENT AND EFFICIENT CULTIVATION
T. Sherman
BETTERSEEDS, R&d, Givat Hen, Israel
AGR: Advanced Agriculture and Production
RESPONSE OF MEDICAL CANNABIS PLANTS TO NITROGEN (N) SUPPLY
A. Saloner, N. Bernstein
Institute of Soil, Water and Environmental Sciences, Volcani Center, Rishon LeZion, Israel
AGR: Advanced Agriculture and Production
EFFECTS OF MAGNESIUM (MG) SUPPLY ON MEDICAL CANNABIS PLANTS
D. Morad, N. Bernstein
Institute of Soil, Water and Environmental Sciences, Volcani Center, Rishon LeZion, Israel